Sedative Hypnotics Flashcards
progression of sedative hypnotics
anxiolysis sedation hypnosis anesthesia death
use of barbiturates
induce anesthesia
rarely used
use of benzodiazepines
anxiety
insomnia
epilepsy
use of non-benzodiazepines (z drugs)
insomnia
safest for use
GABA receptor for sedative/hypnotic
alpha1
GABA receptor for anxiolytic and muscle relaxant
alpha2
GABA receptor for anticonvulsant
alpha3
GABA receptor for amnesia
alpha5
barbiturate action at GABA receptor
increase duration of opening
increases efficacy of GABA
benzodiazepine action at GABA receptor
increase frequency of opening
increases potency of GABA
barbiturates to recognize
thiopental
pentobarbital
amobarbital
phenobarbital
thopental
short acting barbiturate
used for amnesia prior to surgery
phenobarbital
long acting barbiturate
used for seizures
side effects of barbiturates
dose dependent respiratory depression
induction of liver enzymes
low margin of safety
increases porphyrin production- do not use with porphyria
benzodiazepine side effects/toxicity
tolerance to sedation and euphoria
cross tolerance with other CNS depressants
physical dependence- withdrawal symptoms
advantages of benzo use for insomnia over barbiturates
higher margin of safety than barbiturates- plateaus before bad effects
no cyp induction
milder withdrawal
therapeutic use of bentos #1
insomnia- reduces time to sleep and increases total sleep time moderate REM decrease increase stage 2 decrease stage 4 REM rebound when ended
flurazepam half life
40-100 (longest)
flurazepam use
short term mild/moderate insomina
flurazepam activity
prodrug
peak metabolite plasma concentration 1-3h
flurazepam delivery/absorption
good absorption orally
lorazepam half life
10-20hours
lorazepam use
short term mild/moderate insomnia with anxiety
lorazepam activity
slow
no active metabolites
lorazepam delivery/absorption
oral- slow
IM- good
temazepam half life
10-40h
temazepam use
short term severe insomina